Vivani Medical VANI Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsFairValueDisclosure.
The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's cash & equivalents?
- Vivani Medical (VANI) reported cash & equivalents of $19.04M in Q1 2026.
- How has Vivani Medical's cash & equivalents changed year-over-year?
- Vivani Medical's cash & equivalents increased by 57.7% year-over-year, from $12.07M to $19.04M.
- What is the long-term trend for Vivani Medical's cash & equivalents?
- Over 5 years (2020 to 2025), Vivani Medical's cash & equivalents has grown at a 37.6% compound annual growth rate (CAGR), from $3.12M to $15.42M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.